Skip to content

Netherlands logo

Main menu
    • Over ons
    • Onze focus
    • Onze producten
    • Business development
    • Onze leiders
    • Onze cultuur
    • Beleid & standpunten
    • MVO & duurzaamheid (ESG)
    • Diversiteit, gelijkheid & inclusie
    • Nieuws
    • Media
  • Werken bij Organon

Contact

Back
Change Language
  • English
Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA

  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom

  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

Onze leiders

Het internationale leadership team, waarin vrouwen in de meerderheid zijn, stimuleren onze toewijding aan de gezondheid van vrouwen en inspireren ons om meer voor haar te doen.

Executive Leadership Team

Het Executive Leadership Team beheert de strategische richting en activiteiten van ons bedrijf. Met hun brede en gevarieerde ervaringen begeleiden ze wie we zijn en waar we voor staan.

Maak kennis met het teamOpens a new window

Board of Directors

De Raad van Bestuur heeft meer vrouwen dan welk S&P 500 zorgbedrijf dan ook. Onze board-leden brengen ieder vanuit hun eigen achtergrond unieke perspectieven om ons te helpen onze visie waar te maken.

Maak kennis met ons bestuurOpens a new window

Manufacturing Site Leader Organon Oss

Wenny Raaijmakers

Maak kennis met Wenny Raaijmakers

Het bereiken van gendergelijkheid binnen ons bedrijf en over de hele wereld

Als een bedrijf dat zich inzet voor vrouwen, is het bereiken van gendergelijkheid onze plicht. Dit komt tot uiting in onze inzet, leiderschap en onze bedrijfsvoering.

Meer over diversiteit, gelijkheid en inclusie

VVPM job number: NL-NON-110165
Date of last revision: October 8, 2024

Netherlands logo
  • Forward-Looking Statement
  • Cookiebeleid
  • Privacybeleid
  • Gebruiksvoorwaarden
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept